Reaktionsgleichung
CC1(C)C(C)(C)OB([C:9]2[CH:17]=[CH:16][C:12]([C:13]([NH2:15])=[O:14])=[CH:11][CH:10]=2)O1.[F:19][C:20]1[CH:25]=[CH:24][C:23]([C:26]2[C:30]([C:31]3[CH:32]=[CH:33][C:34]4[N:35]([C:37](I)=[CH:38][N:39]=4)[CH:36]=3)=[CH:29][N:28]([C:41]([C:54]3[CH:59]=[CH:58][CH:57]=[CH:56][CH:55]=3)([C:48]3[CH:53]=[CH:52][CH:51]=[CH:50][CH:49]=3)[C:42]3[CH:47]=[CH:46][CH:45]=[CH:44][CH:43]=3)[N:27]=2)=[CH:22][CH:21]=1.P([O-])([O-])([O-])=O.[K+].[K+].[K+]>C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1.CN(C)C=O>[F:19][C:20]1[CH:21]=[CH:22][C:23]([C:26]2[C:30]([C:31]3[CH:32]=[CH:33][C:34]4[N:35]([C:37]([C:9]5[CH:10]=[CH:11][C:12]([C:13]([NH2:15])=[O:14])=[CH:16][CH:17]=5)=[CH:38][N:39]=4)[CH:36]=3)=[CH:29][N:28]([C:41]([C:42]3[CH:43]=[CH:44][CH:45]=[CH:46][CH:47]=3)([C:48]3[CH:49]=[CH:50][CH:51]=[CH:52][CH:53]=3)[C:54]3[CH:59]=[CH:58][CH:57]=[CH:56][CH:55]=3)[N:27]=2)=[CH:24][CH:25]=1Komponenten
6
Edukt 3
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 2
Versuchsvorschrift
222 mg of 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide prepared according to T. Ishiyama et al., J. Org. Chem., 60, 7508 (1995), 323 mg of 6-[3-(4-fluorophenyl)-1-trityl-1H-pyrazolyl]-3-iodoimidazo[1,2-a]pyridine (compound in Production Example 39), 200 mg tripotassium phosphate, 30 mg tetrakis(triphenylphosphine)palladium and 30 mL N,N-dimethylformamide were heated at 75° C. for 3 hours under nitrogen atmosphere. The solvent was removed, and the residue was purified by NH silica gel chromatography (hexane/ethyl acetate) to give 138 mg of the title compound (film).
Aufarbeitung
- customThe solvent was removed
- customthe residue was purified by NH silica gel chromatography (hexane/ethyl acetate)
Quellen und Nachweise
- ORD-Eintrag
- ord-beca258f008742348208e589e2ecd2f0
- Quelldatensatz
- uspto-grants-2006_07
- Patentnummer
- US07074801B1
Verknüpfte Notizen
Wird geladen…